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Wednesday, September 28, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health threats/emergencies and we continue to address
ongoing/emerging disaster issues, the Center for Disaster Medicine has been and will continue to be a source of reliable information, education and
models for mitigation, preparedness, response, and recovery. As such we have expanded this informational document to address the broader areas
addressed by the center while retaining critical COVID19 information. As the pace of new information and changes occur, we will evaluate the current
once per week to determine if this information should be provided on a more frequent basis

                                                                                                                       
David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

616,292,698

6,540,301

12,264,887,818

United States

96,165,319

1,057,298

611,686,655

New Jersey

2,733,220

34,725

18,283,404

New York

6,105,779

71,711

41,469,439

Connecticut

894,428

11,361

8,134,396

Information as of 9/28/22 at 1000 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency Services and Westchester Medical
Center to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify strengths and areas for improvement in
other regions.
Updating and developing new programs to provide enhanced education on public health emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline responders in the hospital and in the
field.
Serving as a source of information for COVID-19 related concerns or questions regarding public health, emergency medical service
(EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using first-person
experiences to highlight current trends.
CDM staff were invited speakers for graduate public health students at NYMC on September 19th and for bachelor nursing students

on September 21st at NYU Nursing School. CDM is constantly involved in raising awareness regarding disaster medicine among
future public and medical professionals.

                                      

The White House
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic and monkeypox
and provide economic relief, tackle climate change, and advance racial equity and civil rights, as
well as immediate actions to reform our immigration system and restore America’s standing in the
world. This website will provide all information in one central location.
https://www.whitehouse.gov

COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website was
launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/

Health and Human Services (HHS)
On September 27, 2022, U.S. Department of Health and Human Services Secretary Xavier Becerra
and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus held
the first U.S.-WHO Strategic Dialogue. Convened under the Biden-Harris Administration, the U.S.WHO Strategic Dialogue provides a platform to maximize the longstanding U.S. government-WHO
partnership, and to protect and promote the health of all people around the globe, including the
American people.
https://www.hhs.gov/about/news/2022/09/27/joint-statement-united-states-of-america-and-worldhealth-organization-on-us-who-strategic-dialogue.html
On September 27, 2022, the Chief Public Health Officer of Canada, Dr. Theresa Tam, and the
United States Assistant Secretary for Health, Admiral Rachel Levine, MD, issued the following joint
statement on the release of a white paper on substance use and harms:
Canada and the United States (U.S.) continue to face an ongoing crisis of overdose deaths. Since
January 2016, opioid toxicity has claimed the lives of more than 30,000 people in Canada. In the
United States, 91,799 people died due to drug overdose in 2020 alone, with 74.8% of those deaths
involving an opioid. Unfortunately, since the start of the COVID-19 pandemic, both countries have
seen major challenges from substance-related harms and deaths.
https://www.hhs.gov/about/news/2022/09/27/joint-statement-chief-public-health-officer-canada-drtheresa-tam-assistant-secretary-health-admiral-rachel-levine-md-substance-use-harms-duringcovid-19.html
On September 27, 2022, the U.S. Department of Health and Human Services (HHS) Deputy
Secretary Andrea Palm received the updated COVID-19 vaccine during a visit to a vaccination
clinic run by YourTown Health at the Palmetto Community Center in Palmetto, Georgia. In addition
to receiving the updated COVID-19 vaccine, Deputy Secretary Palm toured the health center, one
of the tens of thousands of locations across the country with free updated COVID-19 vaccines
available.
https://www.hhs.gov/about/news/2022/09/27/hhs-deputy-secretary-andrea-palm-gets-updatedcovid-19-vaccine.html
On September 23, 2022, The U.S. Department of Health and Human Services (HHS) today
announced a new effort to help uninsured and underinsured Americans access the COVID-19
monoclonal antibody treatment bebtelovimab even after the product became available on the
commercial market last month. Bebtelovimab received FDA emergency use authorization in
February 2022. Since then, the U.S. government has purchased more than 750,000 doses of the
product. Throughout the pandemic, bebtelovimab, along with other COVID-19 therapeutics, have
been provided to states and territories for free. While the federal government has always expected
that bebtelovimab and other COVID-19 therapeutics would ultimately transition to the commercial
market, the timeline to make the transition for bebtelovimab has accelerated without additional
funding from Congress. As a result, the federal procurement and distribution of bebtelovimab
began to phase out and the product became available on the commercial market on August 17.
https://www.hhs.gov/about/news/2022/09/23/hhs-announces-initiative-help-uninsuredunderinsured-americans-access-covid-19-monoclonal-antibody-treatment.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
On September 27, 2022, the NIH released a report regarding a large international study has
confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average
increase in menstrual cycle length of less than one day. The increase was not associated with any
change in the number of days of menses (days of bleeding). Funded by the National Institutes of
Health, the new study included data from nearly 20,000 people from Canada, the United Kingdom,
the United States, Europe and other parts of the world who received any of nine different vaccines.
For most study participants, the increase resolved in the cycle following vaccination.
https://www.nih.gov/news-events/news-releases/study-confirms-link-between-covid-19-vaccinationtemporary-increase-menstrual-cycle-length
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

Centers for Disease Control and Prevention (CDC)        
Monkeypox is a rare disease caused by infection with the monkeypox virus.
Monkeypox virus is part of the same family of viruses as variola virus, the virus that
causes smallpox. Monkeypox symptoms are like smallpox symptoms, but milder, and
monkeypox is rarely fatal. Monkeypox is not related to chickenpox.
For the latest CDC information including symptoms, testing, vaccines and prevention
regarding monkeypox, please visit

https://www.cdc.gov/poxvirus/monkeypox/
According to the CDC, as of September 27, 2022, there are 25,341 cases in the
United States. For the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of September 27, 2022, there are 66,551 cases in the
world. For the latest global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
On September 27, 2022, the CDC provided guidance regarding Reducing Stigma in
Monkeypox Communication and Community Engagement- Helping people make the
best-informed decisions to protect their health and the health of their community from
monkeypox requires providing key prevention information to the public and working
with partners and trusted messengers to ensure information reaches affected
communities. Anyone can get monkeypox, and CDC is carefully monitoring for
monkeypox in the United States. CDC is working to provide frontline healthcare
providers and public health officials with information about what monkeypox looks like
and how to manage the illness. Many—though not all—of the reported cases have
been among gay and bisexual men. Given this, CDC is focusing on identifying and
using specific channels that will directly reach gay and bisexual men across racial,
ethnic, socioeconomic, and geographic backgrounds. In addition to this focused
messaging, CDC is also providing information to a wider audience about symptoms
and the behaviors that can lead to the spread of monkeypox.
https://www.cdc.gov/poxvirus/monkeypox/resources/reducing-stigma.html
As of September 14, 2022, the CDC updated the monkeypox section regarding the
latest information on signs and symptoms, vaccines, prevention, sexual health, cases
and data.
https://www.cdc.gov/poxvirus/monkeypox/index.html
CDC provides updated information about the variants in the United States- The
emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are
significant to public health (e.g., causes more severe disease, spreads more easily
between humans, requires different treatments, changes the effectiveness of current
vaccines). It’s important to understand that genetic mutations are expected, and
some variants can spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths,
and trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

United States Food and Drug Administration (FDA)
As of September 27, 2022, 437 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 300 molecular
tests and sample collection devices, 85 antibody and other immune response tests,
51 antigen tests, and 1 diagnostic breath test. There are 79 molecular authorizations
and 1 antibody authorization that can be used with home-collected samples. There is
1 EUA for a molecular prescription at-home test, 2 EUAs for antigen prescription athome tests, 19 EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for
molecular OTC at-home tests. The FDA has authorized 31 antigen tests and 8
molecular tests for serial screening programs. The FDA has also authorized 1121
revisions to EUA authorizations
https://www.fda.gov/news-events/press-announcements/fda-roundup-september-272022
On September 27, 2022, the FDA Updates COVID-19 Test Policy, Encourages
Developers to Seek Traditional Premarket Review for Most Test Types- the U.S.
Food and Drug Administration updated its COVID-19 test policy to ensure continued
access to tests while encouraging the transition of these important public health tools
to traditional premarket review pathways. The updated policy describes the FDA’s
intent to review only a small subset of new emergency use authorization (EUA)
requests for diagnostic tests and encourages developers of all test types interested in
marketing authorization to pursue authorization through the de novo classification or
510(k) clearance pre-market review pathways.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19update-fda-updates-covid-19-test-policy-encourages-developers-seek-traditional
The FDA created a specific monkeypox response page which serves as a central
source of information regarding diagnostics, vaccines, and therapeutics. For the latest
FDA information regarding monkeypox, please visit
https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/fdamonkeypox-response
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency
Use Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children
6 months to five years. On August 26, 2022, the FDA authorized the emergency use
of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus
Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in individuals 12 through 17 years of age. This authorization follows
a rigorous analysis and evaluation of the safety and effectiveness data conducted by
the FDA. On August 23, 2021, the FDA granted full approval to Pfizer for adults. On
January 31, 2022, the FDA granted full approval to Moderna for adults. Now with two
vaccines with full FDA approval and three vaccines with EUA for adults and children,
the goal is to vaccinate a larger number of persons in the coming months throughout
the United States. As additional vaccines are granted EUA, information for those
vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United StatesCDC provides overall US COVID-19 Vaccine, deliveries and administration, maps,
charts, and data updated daily by 8 PM. This section represents all vaccine partners
including jurisdictional partner clinics, retail pharmacies, long-term care facilities,
Federal Emergency Management Agency and Health Resources and Services
Administration partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The New York State (NYS) Department of Health (DOH) COVID-19 Vaccine Tracker
Dashboard will update New Yorkers on the distribution of the vaccine including the
number of doses received by the state, a breakdown of first or second doses, and the
number of persons vaccinated with the first and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
The NYS DOH provides updated monkeypox information regarding signs and
symptoms, cases, vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to
provide updated relevant information including side effects and safety data, clinical
trials demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of January 31, 2022, the fully
FDA approved Moderna vaccine will now be known as SPIKEVAX for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/differentvaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC Department of Health and Mental Hygiene (DOHMH) updated guidance
regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with
information to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
K-12
On September 19, 2022, Head Start programs are expressing relief
after the U.S. Department of Health and Human Services notified them
late Friday of plans to drop the universal masking requirement for
children, teachers and staff. The requirement had remained in effect
despite changes to COVID-19 guidance from the Centers for Disease
Control and Prevention. In recent weeks, many lawmakers and Head
Start programs have called on the federal agency to drop universal

masking
https://www.k12dive.com/news/health-and-human-services-drops-mask-requirementfor-head-start-programs/632151/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?
recrs=&cond=Covid19&term=&cntry=&state=&city=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recoveredcovid-19-patients.html

State Updates

New York State Department of Health (DOH)
On September 27, 2022, Governor Hochul updated New Yorkers on the state's progress combating COVID-19. "As we
welcome the fall, I urge New Yorkers to remain vigilant, be sure to use the tools that are available to keep themselves,
their loved ones, and their communities safe and healthy," Governor Hochul said. "Take advantage of the vaccine by
staying up to date on doses. Test before gatherings or travel and if you test positive, talk to your doctor about potential
treatment options."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progress-combating-covid-19-351
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information regarding testing, cases,
percentages, and fatalities across New York State. It also breaks down cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home
As of September 27, 2022, there are 3,874 cases of monkeypox in New York State. For the latest monkeypox information
including vaccines and provider information from NYS DOH, please visit:
https://www.health.ny.gov/diseases/communicable/zoonoses/monkeypox/

Connecticut
Governor Lamont Provided Update on Connecticut’s Coronavirus Response Efforts- The Connecticut Department of Public Health is reporting that
as of September 21, 2022, a total of 278,512 cases of COVID-19 among fully vaccinated persons in Connecticut have been identified. Those cases
account for 10.12% of the more than 2.7 million people in the state who are fully vaccinated.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/09-2022/Governor-Lamont-Coronavirus-Update-September-22

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of September 27, 2022, there are 3,555 cases of
monkeypox in New York City. For the latest information including cases, symptoms, testing, and vaccine information regarding monkeypox in New
York City, please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how variants of the virus that causes COVID-19 are
spreading in NYC. Variants are versions of the virus with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

Westchester County Department of Health
For the latest breakdown of COVID-19 positive cases in Westchester County as of September 26, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.
https://health.westchestergov.com/2019-novel-coronavirus
As of September 27, 2022, Westchester County has 87 cases of monkeypox. Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court Street,
White Plains. Appointments are required. People at higher risk for monkeypox infection may consider vaccination with the two-dose JYNNEOS vaccine. In
accordance with CDC guidance, this includes those who:
Had contact with someone who had a rash that looks like monkeypox or with someone who was diagnosed with confirmed or probable monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity; this includes men who have sex with men who meet partners
through an online website, digital application (“app”), or social event such as at a bar or party  
Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox activity has been ongoing
Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 am - 5 pm, appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/

Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of September 23, 2022.
https://www.putnamcountyny.com/covid19/
As of September 27, 2022, there are 5 cases of monkeypox in Putnam County.
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of September 23, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of September 27, 2022, there are 10 cases of monkeypox in Dutchess County. For the latest information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of September 22, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of September 27, 2022, there are 15 cases of monkeypox in Orange County. For more information regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health

Rockland County Department of Health

Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of September 26, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of September 27, 2022, there is 12 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department website
https://rocklandgov.com/departments/health/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

   

Every effort is made to provide accurate and complete information in this newsletter. However, New York Medical College cannot guarantee that
there will be no errors. NYMC makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents of the
newsletters or the articles linked herein and further expressly disclaims liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the advice of your physician or other qualified
health provider with any questions you may have regarding a medical condition.
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